Drug intelligence / Profile preview

Agile PRP

Development stage: Preclinical
Lead developer: Oleolive
Modality: Cell Therapies
Administration: Intravenous

Overview

Agile PRP is a lyophilized (freeze-dried) platelet-rich plasma (PRP) platform developed by Oleolive for the rapid field treatment of acute traumatic non-compressible hemorrhage. Designed for use in austere environments, such as combat zones, the product consists of concentrated platelets and growth factors in a stable powder form. When needed, the powder is reconstituted with sterile saline and administered intravenously to provide immediate hemostatic activity and promote tissue repair. The development of Agile PRP is supported by the U.S. Air Force to address the high mortality rate associated with blood loss from non-compressible wounds where traditional interventions are often unavailable.

Brand names: Agile PRP
Other names: lyophilized platelet rich plasmaAgile PRP platform

Beyond the preview

Go deeper on Agile PRP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agile PRP.

Explore the full profile